Skip to main content

Tempus AI, Inc.

For the period ended Mar 31, 2025. Filed May 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 6, 2025

TEM$80.54-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except per share amounts)

Three Months Ended March 31,
20252024
Net revenue
Genomics$193,804$102,569
Data and services61,93343,251
Total net revenue$255,737$145,820
Cost and operating expenses
Cost of revenues, genomics84,78352,835
Cost of revenues, data and services15,75115,288
Technology research and development33,39127,067
Research and development35,87424,340
Selling, general and administrative154,62779,564
Total cost and operating expenses324,426199,094
Loss from operations$(68,689)$(53,274)
Interest income1,8131,031
Interest expense(18,003)(13,238)
Other (expense) income, net(27,455)749
Loss before benefit from (provision for) income taxes$(112,334)$(64,732)
Benefit from (provision for) income taxes46,180(11)
Losses from equity method investments(1,883)—
Net Loss$(68,037)$(64,743)
Dividends on Series A, B, B-1, B-2, C, D, E, F, G, G-3, and G-4 preferred shares—(27,807)
Cumulative undeclared dividends on Series C preferred shares—(506)
Net loss attributable to common shareholders, basic and diluted(68,037)(93,056)
Net loss per share attributable to common shareholders, basic and diluted$(0.40)$(1.47)
Weighted-average shares outstanding used to compute net loss per share, basic and diluted170,50663,430
Comprehensive Loss, net of tax
Net loss$(68,037)$(64,743)
Foreign currency translation adjustment4,598(56)
Comprehensive loss$(63,439)$(64,799)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.